KEVAHEALTH
OperatingKevaHealth Inc.
Healthcare · Wilmington, DE
Virtual care for respiratory illnesses
Financials
FY2020–FY2023 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps markedA dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Team
10 people
A dynamic and accomplished professional bringing over twenty years of combined experience in academia, regulatory affairs and pharmaceutical industry working in both global and US roles spanning multiple therapeutic areas with a strong foundation in pharmaceutical sciences, digital health, real-world evidence, epidemiology, health outcomes, and pharmacoeconomics. She founded Keva Health which aspires to be a leader in remote care for respiratory illness. Its proprietary platform is integrating innovative remote monitoring functionality with evidence-based self-monitoring programs for patients with chronic respiratory diseases to improve outcomes and reduce costs.
Product & Engineering leader responsible for leading the engineering team with experience in delivering secure, reliable, and resilient platforms and solutions. Oversees both the internal infrastructure and administration as well as production operations. Shail has experience working with startups and large organizations, with the proven ability to produce revenue-generating products. He has worked with hosted and SaaS solutions to create product experiences that delight end users. Shail works 10 hours a week on KevaHealth.
Dr.Shah is CMIO at Compass Medical and serves as strategic advisor for KevaHealth. He is a strong believer and thought leader in advanced digital health, value based care and mentors various digital startup entrepreneurs. Dr. Shah works 1-2 hours a week on KevaHealth.
Dr. Helmuth served as a consultant and in an advisory capacity. With more than 25 years experience as a primary care physician, PJ served as Medical Director of Quality & Population Health for the largest healthcare organization in western Massachusetts and has interests and expertise in clinical quality, value-based care, and virtual care. Dr. Helmuth works 1 hour a week on KevaHealth.
Dr.Ramin is a primary care physician and an in-house expert for hospital at home model of care and ACO model. He serves as hospice director at Elara Caring and is an Executive Advisory Council Member at Angel MD. He is currently bringing connections and helping with fundraising. Ramin works 1-2 hours a week on KevaHealth
With years of experience in pediatric pulmonology, Dr. Divgi plays an essential role with her 40 years of experience with asthma & Chronic Lung Disease patients. Dr. Divgi is the foundation of the Keva teams’ knowledge base within the chronic respiratory space. Dr. Varada Divgi works 2-4 hours a week on KevaHealth.
Show 1 more personShow fewer
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 2 of 4 annual reports (FY2022–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
- Form C-TRMar 26, 20250001665160-25-000491EDGAR
- Form C-AR/AMay 3, 20240001967662-24-000003EDGAR
- Form C-ARMay 1, 20240001967662-24-000002EDGAR
- Form C-UJun 20, 20230001665160-23-001418EDGAR
- Form C/AApr 27, 20230001665160-23-000945EDGAR
- Form C-ARApr 27, 20230001665160-23-000889EDGAR
- Form CMar 7, 20230001665160-23-000373EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.